Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Khristenko, Ekaterina [VerfasserIn]   i
 Sinitsyn, Valentin [VerfasserIn]   i
 Rieden, Tatiana [VerfasserIn]   i
 Girod, Parker [VerfasserIn]   i
 Kauczor, Hans-Ulrich [VerfasserIn]   i
 Mayer, Philipp [VerfasserIn]   i
 Klauß, Miriam [VerfasserIn]   i
 Lyadov, Vladimir [VerfasserIn]   i
Titel:CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer
Verf.angabe:Ekaterina Khristenko, Valentin Sinitsyn, Tatiana Rieden, Parker Girod, Hans-Ulrich Kauczor, Philipp Mayer, Miriam Klauss, Vladimir Lyadov
E-Jahr:2024
Jahr:January 25, 2024
Umfang:12 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 22.07.2024
Titel Quelle:Enthalten in: PLOS ONE
Ort Quelle:San Francisco, California, US : PLOS, 2006
Jahr Quelle:2024
Band/Heft Quelle:19(2024), 1 vom: Jan., Artikel-ID e0291185, Seite 1-12
ISSN Quelle:1932-6203
Abstract:Since computed tomography (CT) is a part of standard diagnostic protocol in pancreatic ductal adenocarcinoma (PDAC), we have evaluated the value of CT for sarcopenia screening in patients with PDAC, intending to expand the diagnostic value of tomographic studies. In our study, we included 177 patients with available CT images. Two groups were formed: Group 1 consisted of 117 patients with PDAC in various locations and stages and Group 2, or the control group, consisted of 60 "nominally healthy" patients with other somatic non-oncological diseases. The body mass index (BMI) was defined as a ratio of patient's weight to the square of their height (kg/m2). CT-based body composition analysis was performed using commercially available software with evaluation of sarcopenia using skeletal muscle index (SMI, cm2/m2). Based on the SMI values, sarcopenia was found in 67.5% of patients (79 out of 117) in the first patient group. It was found more frequently in males (42 out of 56; 75%) than in females (37 out of 61; 60.6%). Additionally, we observed a decrease in muscle mass (hidden sarcopenia) in 79.7% in patients with a normal BMI. Even in overweight patients, sarcopenia was found in 50% (sarcopenic obesity). In patients with reduced BMI sarcopenia was found in all cases (100%). Statistically significant difference of SMI between two groups was revealed for both sexes (p = 0,0001), with no significant difference between groups in BMI. BMI is an inaccurate value for the assessment of body composition as it does not reflect in the details the human body structure. As SMI may correlate with the prognosis, decreased muscle mass- especially "hidden" sarcopenia or sarcopenic obesity- should be reported. The use of CT-based evaluation of sarcopenia and sarcopenic obesity will allow for a better treatment response assessment in patients with cancer cachexia.
DOI:doi:10.1371/journal.pone.0291185
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1371/journal.pone.0291185
 DOI: https://doi.org/10.1371/journal.pone.0291185
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Cachexia
 Carcinoma, Pancreatic Ductal
 Early Detection of Cancer
 Female
 Humans
 Male
 Muscle, Skeletal
 Obesity
 Pancreatic Neoplasms
 Prognosis
 Retrospective Studies
 Sarcopenia
 Tomography, X-Ray Computed
 Wasting Syndrome
K10plus-PPN:1896002803
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69236356   QR-Code

zum Seitenanfang